These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 21060682)
1. Identification and characterization of a leucine-rich repeat kinase 2 (LRRK2) consensus phosphorylation motif. Pungaliya PP; Bai Y; Lipinski K; Anand VS; Sen S; Brown EL; Bates B; Reinhart PH; West AB; Hirst WD; Braithwaite SP PLoS One; 2010 Oct; 5(10):e13672. PubMed ID: 21060682 [TBL] [Abstract][Full Text] [Related]
2. The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Guo L; Gandhi PN; Wang W; Petersen RB; Wilson-Delfosse AL; Chen SG Exp Cell Res; 2007 Oct; 313(16):3658-70. PubMed ID: 17706965 [TBL] [Abstract][Full Text] [Related]
3. Identification of the autophosphorylation sites of LRRK2. Kamikawaji S; Ito G; Iwatsubo T Biochemistry; 2009 Nov; 48(46):10963-75. PubMed ID: 19824698 [TBL] [Abstract][Full Text] [Related]
4. The dual enzyme LRRK2 hydrolyzes GTP in both its GTPase and kinase domains in vitro. Liu Z; West AB Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):274-280. PubMed ID: 27939437 [TBL] [Abstract][Full Text] [Related]
5. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Jaleel M; Nichols RJ; Deak M; Campbell DG; Gillardon F; Knebel A; Alessi DR Biochem J; 2007 Jul; 405(2):307-17. PubMed ID: 17447891 [TBL] [Abstract][Full Text] [Related]
6. LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding. Taymans JM; Vancraenenbroeck R; Ollikainen P; Beilina A; Lobbestael E; De Maeyer M; Baekelandt V; Cookson MR PLoS One; 2011; 6(8):e23207. PubMed ID: 21858031 [TBL] [Abstract][Full Text] [Related]
7. LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease. Xiong Y; Dawson VL; Dawson TM Biochem Soc Trans; 2012 Oct; 40(5):1074-9. PubMed ID: 22988868 [TBL] [Abstract][Full Text] [Related]
8. Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression. Ho DH; Kim H; Kim J; Sim H; Ahn H; Kim J; Seo H; Chung KC; Park BJ; Son I; Seol W Mol Brain; 2015 Sep; 8():54. PubMed ID: 26384650 [TBL] [Abstract][Full Text] [Related]
9. Kinetic mechanistic studies of wild-type leucine-rich repeat kinase 2: characterization of the kinase and GTPase activities. Liu M; Dobson B; Glicksman MA; Yue Z; Stein RL Biochemistry; 2010 Mar; 49(9):2008-17. PubMed ID: 20146535 [TBL] [Abstract][Full Text] [Related]
10. Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal plasticity. Zach S; Felk S; Gillardon F PLoS One; 2010 Oct; 5(10):e13191. PubMed ID: 20949042 [TBL] [Abstract][Full Text] [Related]
12. Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations. Sheng Z; Zhang S; Bustos D; Kleinheinz T; Le Pichon CE; Dominguez SL; Solanoy HO; Drummond J; Zhang X; Ding X; Cai F; Song Q; Li X; Yue Z; van der Brug MP; Burdick DJ; Gunzner-Toste J; Chen H; Liu X; Estrada AA; Sweeney ZK; Scearce-Levie K; Moffat JG; Kirkpatrick DS; Zhu H Sci Transl Med; 2012 Dec; 4(164):164ra161. PubMed ID: 23241745 [TBL] [Abstract][Full Text] [Related]
13. Kinetic, mechanistic, and structural modeling studies of truncated wild-type leucine-rich repeat kinase 2 and the G2019S mutant. Liu M; Kang S; Ray S; Jackson J; Zaitsev AD; Gerber SA; Cuny GD; Glicksman MA Biochemistry; 2011 Nov; 50(43):9399-408. PubMed ID: 21961647 [TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers. Civiero L; Vancraenenbroeck R; Belluzzi E; Beilina A; Lobbestael E; Reyniers L; Gao F; Micetic I; De Maeyer M; Bubacco L; Baekelandt V; Cookson MR; Greggio E; Taymans JM PLoS One; 2012; 7(8):e43472. PubMed ID: 22952686 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease. Li X; Wang QJ; Pan N; Lee S; Zhao Y; Chait BT; Yue Z PLoS One; 2011 Mar; 6(3):e17153. PubMed ID: 21390248 [TBL] [Abstract][Full Text] [Related]
16. Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities. Webber PJ; Smith AD; Sen S; Renfrow MB; Mobley JA; West AB J Mol Biol; 2011 Sep; 412(1):94-110. PubMed ID: 21806997 [TBL] [Abstract][Full Text] [Related]
17. GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2. Biosa A; Trancikova A; Civiero L; Glauser L; Bubacco L; Greggio E; Moore DJ Hum Mol Genet; 2013 Mar; 22(6):1140-56. PubMed ID: 23241358 [TBL] [Abstract][Full Text] [Related]